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Bcl-3 is a member of the family of IkB inhibitors.
Unlike the classical, cytoplasmic IkBs, Bcl-3
does not inhibit RelA- or c-Rel-containing NF-
kB transcription factor dimers. Instead, Bcl-3
can enter the nucleus and modulate NF-kB ac-
tivity, although the underlying mechanism and
physiologic function remain largely unknown.
Here we identified Bcl-3 as a regulator of immu-
nologic tolerance to self. In parallel with NF-
kB2, Bcl-3 functions within stroma to generate
medullary thymic epithelial cells, which are es-
sential for negative selection of autoreactive T
cells. Loss of both NF-kB2 and Bcl-3, but not
either one alone, led to a profound breakdown
in central tolerance resulting in rapid and fatal
multiorgan inflammation. These data reveal ex-
tensive utilization of the NF-kB system to pro-
mote central tolerance in the thymus, in appar-
ent contrast with the well-known roles of NF-kB
to promote inflammation and autoimmunity in
the periphery.
INTRODUCTION
The NF-kB transcription factor family is central to host
defense against pathogenic insults. NF-kB functions as
a primary intracellular mediator of numerous innate, inflam-
matory, and adaptive immune signals (Hayden and Ghosh,
2004). NF-kB has been recognized as well for its essential
roles during development and maintenance of the immune
system, prior to and apparently independent of encounter
with pathogens (Claudio et al., 2006; Siebenlist et al., 2005).
NF-kB factors are also required for proper development
and function of secondary lymphoid organs. Mice defi-
cient in RelB or NF-kB2 or which have inactivating muta-
tions in NIK (aly/aly mice) or in IkB kinase a (IKKa, also
known as IKK1) display an overlapping spectrum of de-
fects in structure and function of secondary lymphoid
organs (Franzoso et al., 1998; Matsushima et al., 2001;
Paxian et al., 2002; Senftleben et al., 2001; Weih and
Caamano, 2003). These mutant mice fail to form proper
B cell follicles and differentiated follicular dendritic cell
networks (FDCs), and, upon challenge, they fail to form438 Immunity 27, 438–452, September 2007 ª2007 Elsevier Incproper germinal centers in spleens. They also lack Peyer’s
patches and, depending on the deficiency of the particular
NF-kB factor, they may lack some or all lymph nodes (see
below). These deficiencies are due in large part to im-
paired stromal cell functions. RelB, NF-kB2, NIK, and
IKKa are all components of the nonclassical pathway for
NF-kB activation. It then follows that the nonclassical
pathway in stromal cells must be essential for proper lym-
phoid organogenesis. Although the nonclassical pathway
is disrupted in NF-kB2-deficient mice, loss of this factor
results in a substantially milder phenotype. For example,
lymph node structures are present (Franzoso et al.,
1998; Weih and Caamano, 2003).
Lymphotoxin b receptors (LTbR) are expressed primar-
ily on stromal cells and upon stimulation engage the non-
classical pathway for NF-kB activation (Basak et al., 2007;
Muller and Siebenlist, 2003). Consistent with a role for
LTbR-mediated activation of the nonclassical pathway
in stromal cells during lymphoid organogenesis, mutant
mouse models deficient in LTbR or its main ligand,
(LTa)1(LTb)2, have defects similar to those described
above for mice lacking components of the nonclassical
pathway (Hehlgans and Pfeffer, 2005; Matsushima et al.,
2001).
Mice blocked in signaling via the LTbR or via the non-
classical pathway share defects in addition to those as-
sociated with lymphoid organogenesis. Mice deficient
in RelB, NIK (aly/aly), and, possibly to a lesser degree,
LTbR signaling display thymic defects and develop
marked multiorgan lymphocytic infiltrations early in life
(Boehm et al., 2003; Chin et al., 2003; Hehlgans and
Pfeffer, 2005; Kajiura et al., 2004; Kinoshita et al., 2006;
Weih et al., 1995). In the case of RelB-deficient mice, the
inflammatory condition can be fatal as early as 7–8 weeks
of age, although there is wide range and mice may survive
for many more months. Such pathology is not seen in NF-
kB2-deficient mice, which develop only mild organ infiltra-
tions relatively late in life, without any effect on their life
span (Franzoso et al., 1998; Weih and Caamano, 2003;
Zhang et al., 2006; Zhu et al., 2006). It is likely that NF-
kB2-deficient mice are largely protected from severe pa-
thology because they retain RelB activity. The absence
of the RelB inhibitor p100 allows p50-RelB dimers to enter
nuclei where they may partially compensate for loss of
RelB dimers (including p52-RelB) activated via the non-
classical pathway (Claudio et al., 2002;Muller and Sieben-
list, 2003)..
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Bcl-3-deficient mice display defects in secondary lym-
phoid organs (Franzoso et al., 1997a; Paxian et al.,
2002). These defects are partly similar to but even milder
than those observed in NF-kB2-deficient mice. Bcl-3 is
structurally related to the IkBa, b, and 3 inhibitors but is
distinct in several critical ways. Bcl-3 is often found in
the nucleus, contains domains that can stimulate tran-
scription, interacts predominantly with p50 and p52 ho-
modimers, and has been reported to directly or indirectly
transactivate or repress gene expression via kB elements
(Bours et al., 1993; Franzoso et al., 1992, 1993; Fujita
et al., 1993; Hayden and Ghosh, 2004). Bcl-3 has also
been implicated in various gene regulatory models and bi-
ologic scenarios (Corn et al., 2005; Kashatus et al., 2006;
Massoumi et al., 2006; Mitchell et al., 2002; Viatour et al.,
2005; Wessells et al., 2004), but its actual physiologic
mechanism(s) of action and in vivo targets remain essen-
tially unknown. Because Bcl-3 is not known to have a di-
rect role in the nonclassical NF-kB signal activation path-
way, the available evidence suggests two basic models
whereby Bcl-3 might influence secondary lymphoid or-
ganogenesis: Bcl-3 could modulate NF-kB activity via di-
rect interaction with p52-NF-kB2, or Bcl-3 could function
in a pathway separate from but partially redundant with
NF-kB2. To address these possibilities, we generated
mice deficient in both proteins. In addition to a complete
block in secondary lymphoid organogenesis, the doubly
deficient mice developed severe lymphocytic infiltrates
in multiple organs. Therefore, Bcl-3 and NF-kB2 have
redundant biologic effects that are revealed only in the
absence of both proteins. We further demonstrated a
profound impairment of central T cell tolerance in these
mutant mice, which could be traced to defects in thymic
stromal cells.
RESULTS
Phenotype of Mice with NF-kB2 and Bcl-3
Deficiency
We generated NF-kB2, Bcl-3 doubly deficient (Nfkb2/
Bcl3/) mice to investigate whether Bcl-3 interacts with
NF-kB2 to modulate its activity or whether these proteins
function in distinct pathways that may nevertheless con-
verge on some common targets. Mice deficient in either
one of these proteins had fully normal life spans and pre-
sented with limited phenotypic defects, mostly resulting
from mildly impaired secondary lymphoid organogenesis,
although Nfkb2/ but not Bcl3/ mice developed mild
inflammation in some organs later in life. Unexpectedly,
loss of both NF-kB2 and Bcl-3 proved fatal by 4 weeks
of age (C57BL/6 background; 3–7 weeks on mixed back-
ground). These Nfkb2/Bcl3/ mice were also small in
size, which became apparent within 2 weeks of birth. By
the time of weaning, the mutant mice began to develop
ruffled fur, scaly skin, a hunched posture, and squinting
eyes, among other symptoms. Further analysis revealed
an absence of all lymph nodes, including mesenteric
lymph nodes, and gradual loss of the thymus, beginningImby about 2 weeks after birth (Figure S1 in the Supplemen-
tal Data available online). Singly deficient mutants had
a normal-sized thymus and contained lymph nodes. Al-
though most lymph nodes were reduced in cellularity in
Nfkb2/ mice, mesenteric lymph nodes appeared com-
pletely normal in both singly deficient mice (Franzoso
et al., 1997a, 1998; Paxian et al., 2002; Weih and
Caamano, 2003). The loss of NF-kB2 and Bcl-3 therefore
generated a new phenotype, supporting the notion that
Bcl-3 and NF-kB2 must have some redundant functional
outcomes, while working independently of each other.
The rapid death ofNfkb2/Bcl3/micewas surprising
and implied activities of the proteins encoded by these
genes in addition to those involved in secondary lymphoid
organogenesis. The appearance of the mice suggested
an inflammatory condition, which was confirmed by tis-
sue analyses. Examination of paraffin-embedded, hema-
toxylin and eosin (H&E)-stained tissue sections from
liver, lung, and skin revealed inflammatory infiltrates
(Figure 1A), which contained many T cells (not shown).
We therefore examined the state of splenic T cells in 3-
to 4-week-old Nfkb2/Bcl3/ mice. Splenocytes from
these mice contained relatively more T cells because ma-
ture B cell numbers were severely reduced (Figure 1B; the
majority of CD4CD8 cells are B cells). Among the T
cells, there was a dramatic increase in the relative
amounts of CD44+CD62L effector and memory cells in
both the CD4 and CD8 compartments when compared
to Nfkb2/ control mice (Bcl3/ mice were similar to
the Nfkb2/ controls; not shown). The Nfkb2/Bcl3/
T cell population also contained more activated cells as
judged by increased expression of the activation markers
CD69 and CD25 (not shown). The increase in effector and
memory (and activated) T cells attested to an ongoing
immune reaction in these mice.
Pathology of Nfkb2/Bcl3/ Mice Is Mediated
by T Cells
The presence of lymphocytic infiltrates in multiple organs
and the pronounced increase in effector and memory T
cells suggested autoimmune reactivity. To test whether
T cells from Nfkb2/Bcl3/ mutants could react with
self-antigens, CD4+ T cells isolated by negative selection
were incubated with wild-type antigen-presenting cells
(APCs) isolated from syngeneic mice (Figure 2A). T-
depleted, irradiated splenocytes served as APCs in this
‘‘syngeneic’’ mixed lymphocyte reaction (MLR). In the ab-
sence of APCs, the T cells did not proliferate, as judged by
thymidine incorporation, except for a very low amount
of proliferation in T cells from the Nfkb2/Bcl3/ mice.
In the presence of (self-antigen-presenting) syngeneic
APCs, T cells isolated fromNfkb2/Bcl3/mice prolifer-
ated at a substantially higher rate than did T cells from the
two single-deficient mice. Nfkb2/Bcl3/ T cells did not
intrinsically proliferate better because nonspecific stimu-
lation with CD3 antibodies did not result in their preferen-
tial growth (data not shown). Together, these data pro-
vided further evidence for the presence of substantial
numbers of autoreactive T cells in Nfkb2/Bcl3/ mice.munity 27, 438–452, September 2007 ª2007 Elsevier Inc. 439
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Bcl-3 and Central ToleranceFigure 1. Nfkb2/Bcl3/ Mice Develop Severe Multiorgan Inflammation
(A) Tissue sections from liver, lung, and skin of nearly 4-week-oldNfkb2/ andNfkb2/Bcl3/micewere stained with hematoxylin and eosin (H&E).
(B) Increased numbers of effector and memory and autoreactive T cells in spleens of Nfkb2/Bcl3/ mice. Splenocytes from 26-day-old Nfkb2/
and Nfkb2/Bcl3/ mice were examined with flow cytometry for the expression of CD4 and CD8 (left) and for expression of CD44 and CD62L on
CD4+ and CD8+ T cells (right).
Data shown are representative of at least five independent experiments.To demonstrate more directly that autoreactive T cells
were responsible for the pathology of Nfkb2/Bcl3/
mice, we isolated CD4+ T cells from these mutant mice
and injected them intravenously into sublethally irradiated
Rag1/mice, which bear no T or B cells of their own. The
recipients showed no obvious ill effects after transfer of
CD4+ T cells from Nfkb2/ or Bcl3/ mice, but all mice
receiving CD4+ T cells from the Nfkb2/Bcl3/ mice
succumbed to the inflammatory condition 8–12 weeks af-
ter transfer (Figure 2B). We observed lymphocytic infil-
trates in these mice, especially in lung and liver, although
the inflammation appeared less than in the original
Nfkb2/Bcl3/ mutant mice (data not shown).
To confirm the requirement of (auto-) antigen-specific
T cells in the development of multiorgan inflammation,
we generated Nfkb2/Bcl3/ mice bearing a transgene
that directs the expression of a T cell receptor (TCR) that is440 Immunity 27, 438–452, September 2007 ª2007 Elsevier IncMHC class I restricted and specific for a peptide from the
chicken ovalbumin protein (OT-I transgene) (Clarke et al.,
2000). Allelic exclusion in OT-I transgenic animals severely
restricts the appearance of endogenous TCRs, and there-
fore the presence of this transgene in Nfkb2/
Bcl3/ mice should largely block the appearance of au-
toreactive T cells and thus prevent the development of pa-
thology. As predicted, the OT-I transgene ‘‘rescued’’ the
Nfkb2/Bcl3/ mice and these mice showed no serious
pathology even by 12 weeks of age, with only sporadic
and limited infiltrates in lung and liver at that time
(Figure 2C; we never observed skin infiltrates). The OT-I
transgene also prevented the dramatic rise in effector
and memory T cells (most T cells on this background are
CD8; data not shown). Together, these data support the
hypothesis that autoantigen-specific T cells mediated
the pathology of Nfkb2/Bcl3/ mice..
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Bcl-3 and Central ToleranceFigure 2. T Cells Mediate Fatal Multiorgan Inflammation in Nfkb2/Bcl3/ Mice
(A) CD4+ T cells purified from spleens of 26-day-old Bcl3/,Nfkb2/, and Nfkb2/Bcl3/mice were cultured with or without irradiated syngeneic
antigen-presenting cells (APCs) (see Experimental Procedures) and pulsed with [3H]thymidine. Data are the mean of triplicates ± SD and similar
results were obtained in three independent experiments.
(B) CD4+ T cells were purified from nearly 4-week-oldBcl3/,Nfkb2/, andNfkb2/Bcl3/mice and transferred into sublethally irradiatedRag1/
mice (53 106 T cells permouse). Recipientmiceweremonitored daily and the surviving proportionwas plotted. Number of independent experiments is
indicated (n) (p = 0.03 for transfer of Nfkb2/Bcl3/ T cells when compared to transfer of Bcl3/ and Nfkb2/ T cells).
(C) The T cell receptor OT-I transgene prevents fatal multiorgan inflammation in Nfkb2/Bcl3/ mice. Liver, lung, and skin sections from nearly
4-week-old Nfkb2/Bcl3/ and 12-week-old Nfkb2/ OT-I and Nfkb2/Bcl3/ OT-I mice were stained with H&E. Data are representative of at
least four independent experiments.T Regulatory Cells
T regulatory (Treg) cells are critical for maintenance of
peripheral tolerance to self-antigens (Ziegler, 2006). Be-
cause the Nfkb2/Bcl3/ mice were unable to control
autoimmune reactions, we postulated that Treg cells
might be fewer or functionally impaired in these mice.
Flow cytometric analysis of splenic T cells from 26-day-
old Nfkb2/Bcl3/ animals did not show reduced num-
bers of CD4+CD25+ Foxp3+ Treg cells (Figure 3A, right).
We also analyzed the thymus of Nfkb2/Bcl3/ mice
at 11 days of age (well before the thymus shrinks) for theImpresence of CD4+CD25+Foxp3+ Treg cells, and we noted
reduced numbers of these cells at this early time relative to
Nfkb2/ mice (Figure 3A, left). Because peripheral Treg
cell numbers just prior to death were not reduced, the rel-
evance of reduced numbers of Treg cells in the thymus
shortly after birth is unclear, but maywell be important, es-
pecially because the thymus started to shrink at 2 weeks
of age (see Discussion).
To test the inhibitory activity of peripheral Treg cells,
wild-type CD4+CD25 naive splenic T cells were activated
in the presence of varied amounts of CD4+CD25+ splenicmunity 27, 438–452, September 2007 ª2007 Elsevier Inc. 441
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Bcl-3 and Central ToleranceTreg cells from either wild-type or Nfkb2/Bcl3/ mice.
The CD25+ Treg cells isolated from Nfkb2/Bcl3/ ani-
mals did not appear to bemarkedly impaired in their ability
to suppress anti-CD3-induced proliferation of wild-type
CD25 T cells (Figure 3B). Together, these data suggest
that the generation and function of peripheral Treg
cells is not globally defective in Nfkb2/Bcl3/ mice,
although thymus-derived Treg cells may be partially
impaired.
Primary Defect of Nfkb2/Bcl3/ Mice
in Stromal Cells
Asdemonstratedabove, autoreactive T cells fromNfkb2/
Bcl3/ mice could induce serious pathology upon trans-
fer. It remained to be determined, however, whether the
Figure 3. Analysis of T Regulatory Cells
(A) 11-day-old Nfkb2/Bcl3/ mice have reduced numbers of
CD4+CD25+Foxp3+ Treg cells in thymus, whereas 26-day-old
Nfkb2/Bcl3/ mice have above normal numbers of Treg cells in
spleen. Thymocytes and splenocytes were gated on CD4+CD8 and
CD4+, respectively, and analyzed for expression of Foxp3 and CD25
with flow cytometry. Example shown is representative of five indepen-
dent experiments.
(B) CD4+CD25+ splenic Treg cells of Nfkb2/Bcl3/mice have near-
normal suppressive activity in vitro.Wild-typeCD4+CD25 T cells were
stimulated with anti-CD3 and pulsed with [3H]thymidine in the pres-
ence of syngeneic antigen-presenting cells (APCs) as well as freshly
isolated CD4+CD25+ Treg cells from spleens of wild-type or Nfkb2/
Bcl3/ mice (see Experimental Procedures). 2-fold dilutions of sup-
pressive Treg cells were used as shown. Data are the mean of tripli-
cates ± SD and are representative of three independent experiments.442 Immunity 27, 438–452, September 2007 ª2007 Elsevier Inccausative defect resided in T cells, other hematopoietic
cells, stromal cells, or a combination of cell types, given
that two proteins were involved. To address this question,
we performed reciprocal bone-marrow transplants. First,
we adoptively transferred bone marrow from Nfkb2/
Bcl3/ mice into lethally irradiated Rag1/ (Figure 4A).
In initial experiments, 3 of 14 recipients of Nfkb2/
Bcl3/ bone marrow developed serious pathology by
12 weeks after transfer, whereas the remaining recipients
showed no marked problems even at 14 weeks. However,
all of the mice receiving Nfkb2/Bcl3/ bone marrow
experienced a transient weight loss after transfer. In con-
trol experiments, none of theRag1/mice receiving bone
marrow from wild-type, Nfkb2/, or Bcl3/ mice devel-
oped pathology or experienced weight loss. Because
whole bonemarrow was transferred in these experiments,
this included some already fully matured T cells. Sufficient
numbers of such mature T cells might have been trans-
ferred to cause overt problems in 3 out of 14 recipients
and at least transient weight loss in all recipients. To
more stringently test whether hematopoietic stem cells
(as opposed to already mature T cells) from Nfkb2/
Bcl3/ mice could cause pathology, we first depleted
bone marrow of CD4+ and CD8+ T cells before transfer
into lethally irradiated mice, in this case Nfkb2/ mice.
None of the recipient mice developed substantial pathol-
ogy or experienced weight loss by 12 weeks after transfer
and even later (a few mice were observed for several ad-
ditional weeks) (Figure 4A). Further analysis of mice re-
ceiving T-depleted bone marrow showed no inflammatory
infiltrates or increases in effector and memory cells
(bottom panels of Figure 4B and data not shown).
Together, these findings led us to conclude that hemato-
poietic stem cells from Nfkb2/Bcl3/ mice were not
sufficient to cause the inflammatory condition. However,
it remained possible that defects intrinsic to hematopoi-
etic cells were nevertheless necessary to develop such
pathology.
To determine whether stromal cells from Nfkb2/
Bcl3/ mice were necessary and sufficient to cause mul-
tiorgan infiltrates, we performed the reciprocal experi-
ment, transferring wild-type bone marrow into Nfkb2/
Bcl3/ mice. Although the Nfkb2/Bcl3/ mice could
not serve as recipients because their health deteriorated
rapidly after birth, the OT-I transgenic Nfkb2/Bcl3/
mice were ideal for this purpose because the TCR trans-
gene largely prevented development of an inflammatory
condition in these mice (see above). Wild-type bone mar-
row was transferred into lethally irradiated, Nfkb2/
Bcl3/ OT-I mice, generating chimeric mice in which he-
matopoietic cells were genetically wild-type (and without
transgene), whereas stromal cells were of Nfkb2/
Bcl3/ origin. All recipient mice succumbed between 5
and 10weeks after transfer (Figure 4C). In control transfers
of bone marrow from wild-type mice into OT-I transgenic,
Nfkb2/ mice, no overt pathology was evident in any
recipients. Tissue analysis of OT-I Nfkb2/Bcl3/ mice
that had received wild-type bone marrow confirmed
severe inflammatory infiltrates in lung, liver, and skin.
Immunity
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bone marrow (controls) did not develop this pathology, al-
though mild infiltration of lung and liver could be observed
in a few individuals (Figure 4B, middle row). Consistent
with these phenotypes, Nfkb2/Bcl3/ mice with wild-
type hematopoietic cells had dramatically increased
CD44+CD62L effector and memory T cell populations
compared with control Nfkb2/ mice with wild-type he-
matopoietic cells (Figure 4D). The latter control chimeric
mice variably exhibited somewhat elevated numbers of ef-
fector and memory cells when compared to normal mice,
consistent with variably observed mild inflammation in
these chimeric mice, although overt, serious pathology
was not observed (Figures 4D and 4B,middle row). Finally,
splenic T cells fromOT-I transgenicNfkb2/Bcl3/mice
reconstituted with wild-type bonemarrow exhibitedmark-
edly higher autoreactivity than controls as judged by pro-
liferation of T cells in a ‘‘syngeneic’’ mixed lymphocyte
reaction (Figure 4E).
Together, these experiments indicated that stromal
cells of the Nfkb2/Bcl3/mice were sufficient to cause
the T cell-mediated autoimmune condition observed in
these mutant mice. Mutant hematopoietic cells, including
T cells, do not appear to have intrinsic functional defects
responsible for development of pathology. Rather,
Nfkb2/Bcl3/ stromal cells shape T cells to become
mediators of the autoimmune condition. It is noteworthy
that loss of NF-kB2 alone resulted in a mild tendency to-
ward development of multiorgan inflammation, especially
in the transfer models, although overt pathology was
never observed.
Primary Defect in Thymic Stroma Is Responsible
for Pathology in Nfkb2/Bcl3/ Mice
Although stromal cells were shown to be critical for devel-
opment of autoimmune pathology in Nfkb2/Bcl3/
mice, it remained to be determined whether the defect
was mediated by peripheral or by thymic stromal cells,
or both. Because the Nfkb2/Bcl3/ mutants were
missing two genetic loci, it remained possible that two
very different stromal cell types were affected. The thymic
stroma is considered essential for negative selection of
autoreactive T cells, resulting in part from the generation
of tissue-restricted, peripheral self-antigens for presenta-
tion by these stromal cells or by crossprimed thymic den-
dritic cells (Anderson et al., 2005; Gallegos and Bevan,
2006). In contrast, autoreactive Treg cells are not elimi-
nated and may even be positively selected by their recog-
nition of self-antigens generated by and displayed on stro-
mal cells (Aschenbrenner et al., 2007; Cabarrocas et al.,
2006). To rigorously test whether the thymic stroma was
sufficient to cause pathology in Nfkb2/Bcl3/ mice,
we carried out fetal thymic stroma transplants into athy-
mic nude mice. Day 14.5 embryonic fetal thymi were col-
lected from double knockout mice or NF-kB2-deficient
control mice (including Nfkb2/ Bcl3+/), and after
a week in culture in the presence of 2-deoxyguanosine
to eliminate all thymocytes, one or two thymic lobes
were transplanted under the renal capsule of nude mice.Im(The outcome of the experiment was the same regardless
of whether thymic lobes originated with Nfkb2/Bcl3/
or Nfkb2/Bcl3/OT-I TCR transgenic animals. The lat-
ter mice were included as a source of thymic stroma to en-
sure that the outcome was not due to a potential transfer
of undetectable numbers of surviving thymocytes. The
transgene should prevent any T cells that might have
been derived from the transferred thymocytes from caus-
ing pathology.) Between 5 and 8 weeks after transfer, 7 of
the 9 nude mice engrafted with Nfkb2/Bcl3/ thymus
succumbed, whereas none of the 10 control transfers
did (Figure 5A). The remaining two recipients of fetal thymi
from Nfkb2/Bcl3/ mice succumbed later, whereas
controls continued to survive, free of overt, serious pathol-
ogy.Consistentwith these results, nudemicewithNfkb2/
Bcl3/ thymi consistently developed substantial inflam-
matory infiltrates in lung and liver, whereas those with
Nfkb2/ thymi only sporadically developed mild infil-
trates during this time frame (Figure 5B). Furthermore,
splenic T cells in the nude recipients of Nfkb2/Bcl3/
thymi displayed a pronounced shift toward the effector
and memory (CD44+CD62L) phenotype when compared
to control recipients receiving Nfkb2/ thymi, even
though these latter transplants already resulted in some-
what elevated numbers of the effector and memory cells
when compared to normal wild-type mice (Figure 5C).
Therefore, loss of both Bcl-3 and NF-kB2 in thymic stro-
mal cells was sufficient to cause pathology, strongly
suggesting that a single cell type was impaired by the
combined loss.
Because NF-kB1 and NF-kB2 double deficiency re-
sulted in complete lack of all lymph nodes, similar to that
seen in Nfkb2/Bcl3/ mice (Franzoso et al., 1997b;
Lo et al., 2006), we transferred fetal thymi from Nfkb1/
Nfkb2/mice into nudemice. These nude recipients suc-
cumbed to inflammatory conditions by 5 to 8 weeks after
transfer (not shown).
We also tested for autoantibody production in nude
mice that had received thymi from Nfkb2/Bcl3/
mice. The original donorNfkb2/Bcl3/mice had a clear
deficit in mature B cells (see above). Consistent with this
deficit in mature B cells, we could not detect autoanti-
bodies in the original donors (not shown). The (nonthymic)
stromal and hematopoietic cells of nude recipients are ge-
netically wild-type, so the presence of autoreactive T cells
should stimulate autoantibody production by B cells. Ini-
tial analyses confirmed that nude mice with Nfkb2/
Bcl3/ thymi did indeed produce some autoantibodies
(Figure 5D).
To investigate whether impaired T regulatory cell activ-
ity could have contributed to the inflammatory pathology,
we cotransferred one WT (or Nfkb2/) thymic lobe and
one Nfkb2/Bcl3/ lobe into nude mice and compared
them to matched nude recipients that had received only
one Nfkb2/Bcl3/ lobe. The presence of the wild-
type thymic lobe largely prevented organ infiltration
(Figure 5E), and it reduced the relative number of
CD44+CD62L effector and memory cells in both the
CD4 and CD8 compartments (Figure 5F). This resultmunity 27, 438–452, September 2007 ª2007 Elsevier Inc. 443
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Bcl-3 and Central ToleranceFigure 4. Stromal Cells Are Responsible for Fatal Multiorgan Inflammation and Increased Numbers of Effector andMemory TCells
in Nfkb2/Bcl3/ Mice
(A) Bone-marrow (BM) cells from Nfkb2/ and Nfkb2/Bcl3/ mice were transferred into lethally irradiated Rag1/ mice. In addition, Nfkb2/
Bcl3/ bone marrow was depleted of CD4+ and CD8+ T cells prior to transfer into Nfkb2/ OT-I mice, as shown. Chimeric mice were monitored
and the surviving proportion was plotted (see Figure 2B for further details).
(B) Liver, lung, and skin sections fromBMchimeras were stainedwith H&E. Genotypes of BMdonors and recipients were as indicated. Data in top two
rows are representative of at least five independent experiments, bottom row representative of two independent experiments.
(C) Wild-type (WT) BM cells were transferred into lethally irradiated Nfkb2/ OT-I and Nfkb2/Bcl3/ OT-I mice (analysis as in [A]).444 Immunity 27, 438–452, September 2007 ª2007 Elsevier Inc.
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tory activity that controlled the inflammatory potential of
the T cells emerging from the mutant thymus. This further
suggests the T regulatory activity of mutant thymi was in
someway impaired because it was unable by itself to con-
trol organ infiltration.
Impaired Differentiation of Medullary Thymic
Epithelial Cells
Having shown that the thymic stroma was sufficient to
cause multiorgan inflammation, we investigated the thy-
mic structures in the Nfkb2/Bcl3/ mice. The thymus
contains medullary and cortical epithelium. Medullary thy-
mic epithelial cells (mTECs) express Aire (autoimmune
regulator), which has been implicated in expression of pe-
ripheral tissue-restricted autoantigens, such as preproin-
sulin-2 and salivary protein 1, and in presentation of such
autoantigens (Anderson et al., 2005; Gallegos and Bevan,
2006). mTECs are thus important for negative selection of
at least some autoreactive thymocytes. Thymic sections
from 10-day-old mice were stained with the UEA-1 lectin,
which detects a subset of mTECs (Surh et al., 1992), and
with the DEC205 antibody, which preferentially stains cor-
tical thymic epithelial cells (cTEC), while also weakly stain-
ing thymic dendritic cells (DCs) in the medulla (Figure 6A;
Witmer-Pack et al., 1995). Additional sections were
stained for other markers of medullary (MTS10, K14, ER-
TR5, and G8.8; not shown) and cortical (ER-TR4) epithe-
lium (Figure S2; Boyd et al., 1993; Farr et al., 1991; Godfrey
et al., 1990; Klug et al., 1998; Van Vliet et al., 1985). The
Nfkb2/Bcl3/ sections appeared to lack fully differenti-
ated medullary epithelial cells, because no clear staining
was seen with UEA-1, ER-TR5, MTS10, or G8.8, whereas
cTECs were readily detected with DEC205 and ER-TR4.
There was, however, some weak staining with K14 in non-
cortical and thus presumablymedullary regions inNfkb2/
Bcl3/ animals. Therefore, mTEC progenitor-like cells
may have been present in medullary regions of Nfkb2/
Bcl3/mutants, but these cells failed to fully differentiate.
Of note, Nfkb2/ thymi appeared to be partially impaired
when compared to wild-type (or Bcl3/) thymi, based on
reduced staining with UEA-1, MTS10, and especially with
G8.8 and ER-TR5. Partial impairment of the thymus in
these mutant mice is consistent with mild inflammatory
tendencies later in life and in transfer experiments (as
shown here and Zhu et al., 2006).
In addition to a loss of differentiated mTECs and possi-
bly as a consequence thereof, we also failed to detect thy-
mic DCs in the medulla of Nfkb2/Bcl3/mutant thymic
sections (Figure 6B, CD11c staining; the result was con-
firmed with MIDC-8 staining; not shown). The absence
of thymic DCs may suggest a more generally impairedImability to negatively select T cells. Finally, natural killer T
(iNKT) cell differentiation and presence in the periphery
has been shown to depend on RelB expression in thymic
stromal cells (Elewaut et al., 2003; Sivakumar et al., 2003).
Consistent with this, we observed a severe loss of iNKT
(CD1d-aGalCer tetramer+) cells in liver and spleen of 2-
week-old doubly deficient mice (data not shown).
To confirm that differentiatedmTECswere not only phe-
notypically but also functionally deficient, we performed
quantitative PCR analyses with RNA extracted from 10-
to 12-day-old thymi for expression of several genes,
including Aire, preproinsulin-2, salivary protein 1, and
Foxn1 (Figure 6C). Thymus RNA from Nfkb2/Bcl3/
mice showed dramatically decreased amounts of Aire, in-
sulin, and salivary protein 1, whereas expression of the
control gene Foxn1 was essentially the same as in wild-
type mice. Thymi from Bcl3/ mice contained near
wild-type amounts of mRNAs for Aire, preproinsulin-2,
and salivary protein 1, whereas Nfkb2/ mice expressed
intermediate amounts of these mRNAs, suggesting a par-
tial problem in the latter mutants, consistent with other ev-
idence discussed above. These results show a profound
loss of mTECs markers and function in Nfkb2/Bcl3/
mice, presumably because of a block in differentiation of
these cells, which in turn is likely to impair negative selec-
tion of autoreactive T cells that recognize self-antigens
such as insulin and salivary protein 1. Loss of differenti-
ated mTECs and thus expression of TSAs most likely
also impacted Treg cells.
DISCUSSION
The data presented here implicate Bcl-3 and NF-kB in
the control of immunological self-tolerance. Although
Bcl-3 by itself is not absolutely necessary for central toler-
ance, its importance is revealed in the absence of
NF-kB2. Mice lacking both NF-kB2 and Bcl-3, but not
mice lacking one of these proteins, failed to survive past
4 weeks after birth, exhibiting severe multiorgan inflam-
mation. Thus, NF-kB2 and Bcl-3 have functionally redun-
dant roles in preventing the immune system from attack-
ing its host. Interestingly, these proteins also have
redundant functions during lymphoid organogenesis be-
cause only doubly deficient, but not singly deficient, mu-
tants lack all lymph nodes.
Thymi of Nfkb2/Bcl3/ animals lack differentiated
medullary thymic epithelial cells (mTECs) but do contain
noncortical, medullary-like areas. Wild-type thymus con-
tains clusters or networks of differentiated mTECs that
can be identified with a limited set of surface markers,
some of which differentiate subclasses of mTECs. mTECs
are the source of various peripheral tissue-specific(D) T cells from WT BM-reconstituted Nfkb2/ OT-I and Nfkb2/Bcl3/ OT-I mice were gated on CD4+ and analyzed for expression of CD44 and
CD62L by flow cytometry. Data representative of at least five independent experiments.
(E) T cells from WT BM-reconstituted Nfkb2/Bcl3/ OT-I mice show elevated autoreactivity. APC, syngeneic antigen-presenting cells. The graph
shows increasing ratios of APC to constant amounts of CD4+ T cells. Data are the mean of triplicates ± SD and similar results were obtained in two
independent experiments; see Figure 2A for further details.
(B, D, and E) Tissues and cells were from mice 6–7 weeks after transfer.munity 27, 438–452, September 2007 ª2007 Elsevier Inc. 445
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Bcl-3 and Central ToleranceFigure 5. Engraftment of Athymic Nude Mice with Fetal Thymus Tissue from Nfkb2/Bcl3/ Mice Causes Multiorgan In-
flammation
(A) Nude mice engrafted with (T-depleted) fetal thymus lobes from Nfkb2/ and Nfkb2/Bcl3/mice (with and without OT-I transgene) were mon-
itored and the surviving proportion was plotted (see Figure 2B for further details).
(B) H&E-stained sections from liver and lung of nude mice engrafted 6 weeks prior with fetal thymus from Nfkb2/ or Nfkb2/Bcl3/ mice.
(C) Splenic T cells from nude mice engrafted 5 weeks prior with fetal thymus from Nfkb2/ or Nfkb2/Bcl3/ mice were gated on CD4+ and CD8+
and analyzed for expression of CD44 and CD62L by flow cytometry.
(B and C) Representative examples of at least five independent experiments are shown.446 Immunity 27, 438–452, September 2007 ª2007 Elsevier Inc.
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Bcl-3 and Central Toleranceantigens (TSAs) in the thymus, such as insulin and salivary
protein 1. mTECs may present these self-antigens directly
to newly developing TCR+ T cells or indirectly via cross-
priming of local thymic DCs (Anderson et al., 2005;
Aschenbrenner et al., 2007; Gallegos and Bevan, 2006).
Nfkb2/Bcl3/ thymi lack these differentiated mTEC
clusters, as judged by the absence of surface markers
and as judged also by lack of expression of insulin, salivary
protein 1, and Aire. Expression of Aire is largely restricted
to mTECs, where it functions as a transcriptional regulator
for expression of TSAs. Aire may also have a more general
role in presentation of self-antigens (Anderson et al.,
2005). Lack of TSAs and Aire in Nfkb2/Bcl3/ mice is
presumably a consequence of impaired differentiation of
mTECs, although this does not rule out the possibility of
a more direct role of NF-kB2 and Bcl-3. In addition to
mTECs, Nfkb2/Bcl3/ mice are missing thymic DCs.
These cells normally reside in the medulla and the cor-
tico-medullary junctions; they have been implicated in
negative selection of T cells to self-antigens in general
and to TSAs via crosspriming in particular (Aschenbrenner
et al., 2007; Gallegos and Bevan, 2006; Gavanescu et al.,
2007). Their absence is likely to be secondary to the
absenceofdifferentiatedmTECsbecauseweobservednor-
mal numbers of thymic DCs in lethally irradiated Rag1/
mice whose hematopoietic compartment had been regen-
erated upon transfer of Nfkb2/Bcl3/ bone marrow
(data not shown). We reason that lack of mTEC-dependent
local expression of TSAs, coupled with lack of thymic DCs,
in Nfkb2/Bcl3/ mice impairs negative selection of T
cells recognizing TSAs and possibly also other antigens.
Defective negative selection could be a primary cause of
the observed fatal multiorgan inflammatory pathology.
The lack of differentiated mTEC clusters may also pre-
vent the emergence of Treg cells that recognize TSAs. It
has been postulated that Treg cells are positively selected
in thymus by recognition of self-antigens presented by
mTECs (Aschenbrenner et al., 2007; Cabarrocas et al.,
2006). If so, our Nfkb2/Bcl3/ animals may suffer
from holes in the repertoire of their Treg cells for this class
of self-antigens; such a defect may account for the ob-
served reduction of thymic Treg cells shortly after birth.
Treg cells emerging from the thymus have been referred
to as natural Treg cells, differentiating them from adaptive
Treg cells that may develop in the periphery in response to
specific antigenic challenges (Bluestone and Abbas,
2003). In addition to possible holes in the natural Treg
cell repertoire, it is conceivable that Treg cells were also
functionally impaired in vivo at sites of inflammation, al-
though nonspecific inhibitory activity did not appear to
be compromised. The notion that Treg cell surveillanceImwas somehow impaired in Nfkb2/Bcl3/ mice is sup-
ported by the finding that cotransplantation of wild-type
thymus and Nfkb2/Bcl3/ thymus markedly reduced
inflammatory pathology, presumably resulting from wild-
type thymus-derived Treg cells exerting control over T
cells emerging from the defective thymus. A deeper un-
derstanding of the development and functions of natural
and adaptive Treg cells will be required to determine
whether and how Treg cells of Nfkb2/Bcl3/ mice
may have failed to control multiorgan infiltration.
Nfkb2/Bcl3/ mice bear striking similarities to mice
lacking RelB and mice mutated in NIK (aly/aly). These mu-
tant mice fail to develop lymph nodes, lack fully differenti-
atedmedullary epithelium, and developmultiorgan inflam-
mation, although theydiffer in the severity of thepathology,
with the present Nfkb2/Bcl3/ exhibiting the most se-
vere form (Kajiura et al., 2004; Weih et al., 1995). Defects
intrinsic to various cell types have been suggested to con-
tribute to the pathology of RelB-deficient mice (Martin
et al., 2003; Xia et al., 1999). We found that transplantation
of thymic tissue from RelB-deficient thymus caused multi-
organ infiltration in nude mice (data not shown), similar to
thymic tissue from Nfkb2/Bcl3/ mice, aly/aly mice,
and IKKa-deficient mice (Kajiura et al., 2004; Kinoshita
et al., 2006). Therefore, the severe inflammation observed
in these mutant mouse models is due first and foremost to
defects intrinsic to thymic stroma, andmost likely tomTEC
precursor cells, regardless of whether other cells were
affected and contributed to the final phenotype as well.
The results obtained with mice lacking components of
the nonclassical pathway (discussed above) clearly point
out a crucial role of this pathway and its RelB target for in-
duction of tolerance in the thymus. Activation of the non-
classical pathway in mTEC precursors must include sig-
naling via the lymphotoxin b receptor (LTbR) because
loss of this signaling route results in multiorgan inflamma-
tion as well (Boehm et al., 2003; Chin et al., 2003; Hehl-
gans and Pfeffer, 2005). It has recently been reported
that the LTbR activates NF-kB only via the nonclassical,
not the classical, pathway, so loss of NF-kB2 should abol-
ish all LTbR signaling to NF-kB (Basak et al., 2007). Never-
theless, Nfkb2/ mice have a much milder phenotype
than might be predicted from this, with only mild sporadic
inflammation after at least 6 months of age, as described
here and elsewhere (Zhu et al., 2006). The likely explana-
tion is that RelB complexes can still be activated in
Nfkb2/ mice, because only these mutants lack the
p100 inhibitor. We have shown previously that TNFa
strongly activates p50-RelB in Nfkb2/, but not wild-
type cells, and that it does so via classical pathway-
induced expression of both RelB and NF-kB1 (Muller(D) Nude mice engrafted with fetal thymus from Nfkb2/Bcl3/ mice exhibited elevated autoantibodies when compared to nudes engrafted with
Nfkb2/ fetal thymus. Serumwas collected frommatched nudes between 5 and 7weeks after transplantation. Serum antibody titers to the indicated
autoantigens were determined with ELISA assays (1:100 dilution for anti-IgG, 1:200 dilution for anti-insulin; p = 0.047 and p = 0.03, respectively).
(E) H&E-stained sections from liver and lung of nudemouse engrafted 10 weeks prior with one fetal thymic lobe from aNfkb2/Bcl3/mouse or with
the other fetal thymic lobe from the same Nfkb2/Bcl3/ mouse and one lobe from a WT mouse.
(F) Splenic T cells were isolated from the thymic stroma-engrafted nude mouse shown in (E) were gated on CD4+ and CD8+ and analyzed for expres-
sion of CD44 and CD62L by flow cytometry.
(E and F) The engrafted nude mouse is a representative example of six other such matched transfers.munity 27, 438–452, September 2007 ª2007 Elsevier Inc. 447
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Bcl-3 and Central ToleranceFigure 6. Disrupted Thymic Architecture and Phenotypic and Functional Loss of Medullary Thymic Epithelial Cells in Nfkb2/
Bcl3/ Mice
(A) Thymic tissue sections of 10-day-old wild-type (WT), Bcl3/, Nfkb2/, and Nfkb2/Bcl3/ mice were stained with UEA-1 (mTECs) and the
DEC205 antibody (primarily staining cortical TECs, but also thymic dendritic cells).
(B) Thymic tissue sections of 14-day-old WT, Nfkb2/, and Nfkb2/Bcl3/ mice were stained with CD11c (thymic dendritic cells).
(A and B) Representative examples of at least four independent experiments are shown.
(C) Quantitative PCR analysis of RNA from 10- to 12-day-old WT, Bcl3/, Nfkb2/, and Nfkb2/Bcl3/ thymi for expression of Foxn1 (control),
Aire, and the peripheral tissue antigens salivary protein 1 and preproinsulin-2 (Insulin 2). Data are shown as the mean ± SD of 3–5 mice per group.and Siebenlist, 2003). We therefore wondered whether
Bcl-3 might be required for TNFa-induced activation of
p50-RelB in Nfkb2/ cells, which could explain the dra-
matic phenotype of Nfkb2/Bcl3/ mice. However, we
were unable to detect any role for Bcl-3 in TNFa-induced
p50-RelB activity (data not shown). We conclude that in
the present biologic context, Bcl-3 likely functions by448 Immunity 27, 438–452, September 2007 ª2007 Elsevier Incdirectly regulating target genes, not indirectly via global
effects on NF-kB activity. The genes involved in the differ-
entiation of mTECs are not known. Future work will have
to identify such genes, those among them targeted by
Bcl-3, RelB, or any of the NF-kB factors, and the molec-
ular mechanisms by which these factors regulate their
expression..
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Bcl-3 and Central ToleranceTo date, little is known about physiologic targets of Bcl-
3 in any biologic context; furthermore, actual mechanisms
of recruitment to and functions within chromatin of poten-
tial direct targets remain unknown or unconfirmed, al-
though Bcl-3 does strongly interact with homodimers of
p52 (NF-kB2) and p50 (NF-kB1). In the present biologic
context, Bcl-3 must function independent of p52, but
could still function in concert with p50. There is indirect
support for a model wherein Bcl-3’s contributions to toler-
ance might be mediated via p50, as indicated by the fact
that RelB, NF-kB1 doubly deficient mice develop a more
severe form of multiorgan inflammation than mice defi-
cient in RelB only (Weih et al., 1997). Therefore, Bcl-3
and p50 may interact to help differentiate mTECs and
induce tolerance.
It also remains to be determined how and by which sig-
nal Bcl-3 is activated during mTEC differentiation. In addi-
tion to LTbR signals, differentiation of mTECsmust involve
at least one other signal. Thymi of TRAF6-deficient mice
lack differentiated mTECs, and their transplantation into
nude mice induces multiorgan inflammation, even though
TRAF6 is not a known component of the LTbR pathway
(Akiyama et al., 2005). The TRAF6-mediated signal may,
however, contribute indirectly to the nonclassical pathway
by inducing expression of RelB. Bcl-3 andRelB could both
lie downstream of the TRAF6-associated signal. TRAF6
can activate the classical NF-kB pathway, which is known
to induce expression of Bcl-3 (Ge et al., 2003).
The present work suggests extensive parallels between
thymic stromal cells, specifically mTECs, and stromal cells
of secondary lymphoid organs, specifically follicular den-
dritic cells (FDCs). FDCs and mTECs are highly differenti-
ated cells that serve as APCs for B and T cells, respec-
tively. Based on the above data, Bcl-3 and NF-kB2 are
critically involved in the differentiation of both cell types,
as are the nonclassical pathway and RelB. In addition, dif-
ferentiation of mTECs and FDCs is partially controlled by
LTbR ligands expressed on interacting T or B lympho-
cytes, respectively (Boehm et al., 2003; Chin et al., 2003).
The results presented here reveal an unanticipated role
of Bcl-3 in central tolerance, which emerges in the ab-
sence of NF-kB2. Bcl-3 functions redundantly with NF-
kB2; it partially compensates for loss of NF-kB2 and
thus loss of the nonclassical pathway of activation. Based
on these data, it will be important to investigate whether
Bcl-3 is deregulated in human autoimmune diseases. It
will also be of interest to explore possible connections be-
tween Bcl-3’s roles in tolerance induction and tumorigen-
esis. Bcl-3 has been implicated as an oncogene in a variety
of hematologic and solid tumor malignancies (Kashatus
et al., 2006; Massoumi et al., 2006). Further work is
needed to elucidate the precise molecular mechanisms
and targets of Bcl-3 underlying its various roles.
EXPERIMENTAL PROCEDURES
Mice
Bcl3/ andNfkb2/mice were described previously (Franzoso et al.,
1997a, 1998). Both have been backcrossed to C57 BL/6 for 11 or moreImgenerations. Nfkb2/Bcl3/ mice were obtained by crossbreeding
single-deficient mice. Mice were housed in NIAID Institute facilities,
and all experiments were done with approval of the NIAID Animal
Care and Use Committee and in accordance with all relevant institu-
tional guidelines.
Antibodies and Flow Cytometry
Flow cytometric analyses were performed on freshly prepared, eryth-
rocyte-lysed single-cell suspensions of thymocytes or splenocytes in
PBS/0.5% BSA/2 mM EDTA. Stained cells were analyzed on a FACS-
CaliburTM (BD Biosciences) with the following: FITC-, PE-, PerCP-, or
allophycocyanin-conjugated monoclonal antibodies purchased from
BD Biosciences (clone name in parentheses). For surface marker
staining, single-cell suspensions from thymus and spleen were prein-
cubated with anti-FcgIII/II receptor (2.4G2) to block Fc receptors, and
then stained with anti-CD4 (RM4-5), anti-CD8 (53-6.7), anti-CD25
(PC61), anti-CD44 (IM7), anti-CD62L (MEL-14). For Foxp3 intracellular
staining, cells were fixed after surface staining and then stained with
anti-Foxp3 (FJK-16 s) (eBioscience). Data were analyzed with FlowJo
software (Tree Star Inc.).
Cell Purification
Erythrocyte-lysed, single-cell suspensions from spleen served as sple-
nocytes. For autoreactive assays, CD4+ T cells were purified from sple-
nocytes by negative selection onmidiMACS (magnetic cell separation)
columns (Miltenyi Biotec) according to the manufacturer’s instruc-
tions. Antigen-presenting cells (APCs) were prepared from wild-type
splenocytes by depletion of T cells with anti-CD4 and anti-CD8 beads
with MACS. For isolation of CD4+CD25+ T cells or CD4+C25 T cells,
CD4+ T cells obtained by negative selection with MACS (see above)
were incubated with Fc receptor-blocking antibody 2.4G2, then
stained with FITC-anti-CD4, PE-anti-CD8, and PerCP-anti-CD25,
and finally sorted with a FACSAria cell sorter (BD Biosciences).
Adoptive Transfer of CD4+ T Cells
5 3 106 CD4+ T cells, purified from splenocytes by negative selection
(see above), were injected intravenously into sublethally irradiated (500
rads) male rag1/ mice. Mice were weighed weekly and monitored
daily.
Bone-Marrow Chimeras
Bone-marrow cells were harvested by flushing mouse femurs and tib-
ias with cold Hank’s Balance Salt Solution (HBSS). Bone-marrow cell
suspensions were depleted of T cells by magnetic cell separation
with beads conjugated to anti-CD4 and anti-CD8 (Miltenyi Biotec).
3–5 3 106 erythrocyte-lysed bone-marrow cells were injected into
the tail veins of lethally irradiated (900 rads) recipient mice in 0.2 ml
HBSS. Mice were weighed weekly and monitored daily.
T Cell Assays
For mixed lymphocyte reactions, 1 3 105 negatively selected CD4+ T
cells per well were incubated with 53 105 (unless otherwise specified)
syngeneic, T cell-depleted, irradiated splenocytes (3000 rads) serving
as (self-) antigen-presenting cells (APCs) in 96-well plates for 72 hr and
pulsed with 1 mCi of [3H]thymidine per well for final 8 hr. T regulatory
cell-mediated suppression assays were performed under the same
conditions, except with 5 3 104 CD4+CD25 T cells as responders,
2.5 3 105 APCs, anti-CD3 (1 mg/ml) (BD Biosciences), together with
2-fold dilutions of CD4+CD25+ T regulatory cells (as specified).
Autoantibodies
For titers of antibodies to IgG and insulin (Sigma), 96-well plates were
coated with these antigens (10 mg/ml in phosphate-buffered saline) at
37C for 2 hr. Plates were subsequently washed 3 times and then in-
cubated with blocking buffer (BBS, 0.05% Tween 20, 1 mM EDTA,
0.25% NaN3) at room temperature for 30 min. After three rinses, the
plates were incubated with 50 ml diluted sera (1:50, 1:100, 1:200)
then incubated at room temperature for 2 hr. Antibodies were detectedmunity 27, 438–452, September 2007 ª2007 Elsevier Inc. 449
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or IgM (Jackson Immunoresearch).
Histopathology and Immunohistochemistry
Organs and tissueswere immersion fixed in 10%buffered formalin and
embedded in paraffin blocks. Sections were stained with hematoxylin
and eosin (H&E) and examined by light microscopy. Thymi were em-
bedded in OCT freezing solution. Cryostat sections were fixed for 10
min in ice-cold acetone, then sequentially blocked with peroxidase
blocking reagent (DakoCytomation), avidin/biotin blocking kit (Vector
Laboratories), and blocking buffer containing 10% rabbit or goat se-
rum and incubated with biotinylated ulex europaeus agglutinin 1
(UEA-1; Vector Laboratories) or antibody to DEC205 (Serotec), MTS-
10 (gift of R. Boyd), Keratin 14 (Covance), ER-TR4 and ER-TR5 (gift
of W. van Ewijk), MIDC-8 (Covance), and CD11c (BD Biosciences) at
4C overnight. Staining was developed directly or after incubation
with the appropriate biotinylated second step antibody via StreptAB-
Complex-HRP (streptavidin complexed with biotinylated peroxidase),
according to the manufacturer’s recommendations (Vector
Laboratories).
Fetal Thymus Transplantation
Thymic lobes were isolated from timed embryos 14.5 days after coitus
and were cultured for 6–7 days on Nucleopore filters placed in com-
plete medium containing 1.35 mM 2-DG (Sigma), then washed twice
for 2 hr each. Thymic lobes were transplanted under the renal capsule
of adult (6–8 weeks of age) male B6/nu mice.
RNA Isolation and Real-Time PCR
Thymi were frozen and ground on dry ice, and powder tissue was used
for RNA isolation. 1 ml of TRIzol (Invitrogen) was added to 100 mg of
powder tissue and homogenized with a needle syringe, and then 200
ml of chloroform was added and mixed by vortex. Aqueous phase
was harvested to a new tube after 15 min centrifugation at high speed,
and then 500 ml of isopropanol was added. RNA preparation was incu-
bated 10–20 min on ice and followed by 10 min centrifugation at high
speed. RNA Pellet was dissolved in 100 ml of DEPC-H2O and the RNA
cleanup/Dnase digestion protocol of QIAGENe was followed. 2 mg
RNA was used for cDNA synthesis with superscriptII RT (Invitrogen).
For quantification of gene expression with real-time PCR, 1 ml of the
cDNA reaction mix was used with the platinum quantitative PCR super
Mix-UDG and LUX primers (Invitrogen), according to manufacturer’s
instructions for the Corbett Rotor-Gene real-time machine.
LUX primers were designed with D-LUX Designer software available
on the Invitrogen Web site. The primer sequences were as follows.
GAPDH: 50-CACCATCGTCCCGTAGACAAAATGG[FAM]G-30, 50-CAA
ATGGCAGCCCTGGTGA-30; Foxn-1: 50-CCACTCTTCCCAAAGCCCA
TC-30, 50-CGGAACACTGACTGGAAGGCTTC[FAM]G-30; Aire: 50-CGT
GACGGACGACTCTGCTAGTCA[FAM]G-30, 50-GCAGGATGCCGTCA
AATGAGT-30; Salivary protein-1: 50-CAACACTCCTGGCACTCCTT
GTG[FAM]TG-30, 50-CTGTTTGTCTCCGGGTCCTG-30.
For quantification of preproinsulin 2, 1 ml of cDNA reaction synthesis
was used with platinum SYBR green quantitative PCR super Mix-UDG
(Invitrogen) and the following primers: Preproinsulin2: 50-GCCCT
AAGTGATCCGCTACAATC-30, 50-TCTACAATGCCACGCTTCTGC-30;
b-actin: 50-GTGGGCCGCTCTAGGCACCAA-30, 50-CTCTTTGATGTCA
CGCACGATTTC-30.
Supplemental Data
Two figures are available at http://www.immunity.com/cgi/content/
full/27/3/438/DC1/.
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